Workshop - Munich, Germany
Externalization through product licensing, program partnerships, or company acquisitions is set to be the leading growth strategy for pharma companies. Traditionally, less attention has been paid to scientific elements of due diligence than to commercial assessments. This can lead to post deal issues where the newly acquired product fails to create value for the pharma business.
A successful due diligence process requires a thorough understanding of product-specific development and regulatory requirements aligned to commercial priorities. It encompasses research and analysis conducted for the benefit of the decision-maker before embarking on a partnership. The due diligence exercise should provide a recommendation, after evaluation of all risks, as to whether an alliance should be pursued with the potential partner.
Experienced experts will work through the fundamentals of due diligence that you need to know including interesting case studies and panel discussions. In particular the following will be covered:
- How to set up the process for success
- How to evaluate early and late stage assets from a scientific and regulatory perspective
- How to conduct commercial due diligence
- How to perform a useful gap analysis
- How to mitigate uncertainties and risks for the parties involved
- How to set up communication strategies internally and externally
- How to best integrate due diligence outcomes into contract deals
- How to create an informed decision strategy
- How to “play” with different scenarios
- Organization: EUCRAF
Mon, Jun 29, 2015 - Mon, Jun 29, 2015
Novotel Munich City
Hochstraße 11, 81669, Munich, Germany
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.